Modulation of an allergic immune response via the mucosal route in a murine model of inhalative type-I allergy

International Archives of Allergy and Immunology

Volumn 118, Issue 2-4, 1999, Pages 129-132

  Wiedermann, Ursula ^a   Jahn Schmid, B ^b   Repa, A ^b   Kraft, D ^b   Ebner, C ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Aerosol; Allergy; BALB c; Cholera toxin B conjugates; Mucosal tolerance; Th2

Indexed keywords

CHOLERA TOXIN; GAMMA INTERFERON; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; POLLEN ANTIGEN;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SKIN TEST; T LYMPHOCYTE;

EID: 0032915068     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024048     Document Type: Conference Paper

References (17)

1. Wüthrich B, Schindler C, Leuenberger P, Ackermann-Lieblich U: Prevalence of atopy and pollinosis in the adult population of Switzerland. (SAPALDIA study). Study on air pollution lung disease in adults. Int Arch Allergy Immunol 1995;106:149-156.
2. Ipsen H, Loewenstein H: Isolation and characterization of the major allergen of birch pollen (Betula verrucosa). J Allergy Clin Immunol 1983;72:150-159.
3. Jarolim E, Rumpold H, Endler AT, Ebner H, Scheiner O, Kraft D: IgE and IgG antibodies of patients with allergy to birch pollen as tools to define the allergen profile of Betula verrucosa. Allergy 1989;44:385-395.
4. Breiteneder H, Pettenburger K, Bito A, Kraft D, Rumpold H, Scheiner O, Breitenbach M: The gene coding for the major birch pollen allergen, Bet v 1, is highly homologous to a pea disease resistance response gene. EMBO J 1989;8:1935-1938.
5. Bousquet J, Becker WM, Hejjaoui I: Differences in clinical and immunological reactivity of patients allergic to grass pollen and to multiple-pollen species. II. Efficacy of a double blind placebo controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol 1991;88:43-53.
6. Ebner C, Siemann U, Bohle B, Willheim M, Wiedermann U, Schenk S, Klotz F, Ebner H, Kraft D, Scheiner O: Immunological changes during specific immunotherapy of grass pollen allergy: Reduced lymphoproliferative responses to allergen and shift from Th2 to Th1 in T cell clones specific for Ph1 p1, a major grass pollen allergen. Clin Exp Allergy 1997;27: 1007-1015.
7. Mowat AM: Oral tolerance and regulation of immunity to dietary antigens; in Ogra P, Mestecky J, Lamm ME, Strober W, McGhee JR (eds): Handbook of Mucosal Immunology. New York, Academic Press, 1994, pp 185-201.
8. Weiner HL: Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997;18:335-343.
9. Strobel S, Mowat AM: Immune responses to dietary antigens: Oral tolerance. Immunol Today 1998;19:173-181.
10. Elson CO, Eadling W: Gerneralized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 1984;132:2736-2741.
11. Sun JB, Holmgren J, Czerkinsky C: Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci USA 1994;91:10795-10799.
12. Bergerot I, Ploix C, Petersen J, Moulin V, Rask C, Fabien N, Lindblad M, Mayer A, Czerkinsky C, Holmgren J, Thivolet C: A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci USA 1997;94:4610-4614.
13. Wiedermann U, Jahn-Schmid B, Fritsch R, Bauer L, Renz H, Kraft D, Ebner C: Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: Cholera toxin induces a Th1-like immune response to Bet v 1, the major birch pollen allergen. Clin Exp Immunol 1998;111:144-151.
14. Bauer L, Bohle B, Jahn-Schmid B, Wiedermann U, Daser A, Renz H, Kraft D, Ebner C: Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant epitope from the major birch pollen allergen Bet v 1. Clin Exp Immunol 1997;107:536-541.
15. McSorley SJ, Rask C, Pichot R, Julia V, Czerkinsky C, Glaichenhaus N: Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate. Eur J Immunol 1998;28:424-432.
16. Groux H, O'Garra A, Antonenko S, de Vries JE, Roncarolo MG: A CD4+ T cell subset inhibits antigen specific T cell responses and prevents colitis. Nature 1997;389:737-742.
17. Haneda K, Sano K, Tamura G, Sato T, Habu S, Shirato K: TGFβ induced by oral tolerance ameliorates experimental tracheal eosinophilia. J Immunol 1997;159:4484-4490.